SLS

SELLAS LIFE SCIENCES GROUP I

SLS·81642T209·US·Common Stock·Healthcare - Biotechnology-13D/G

SLS (SELLAS LIFE SCIENCES GROUP I) is held by 107 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($222.4M), STATE STREET CORP ($191.8M), VANGUARD CAPITAL MANAGEMENT LLC ($121.4M). Net institutional sentiment: Bullish.

107
Holders
(8 Elite)
$954.3M
Total Value
78% (116)
Consensus
91 buying - 25 selling
13F: Insider & Congress: Updated regularly
SLS

Smart Money Verdict

View all
Loading verdict
Held by 107 funds
8 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders Nov 21, 2025 · Activists Aug 7, 2026 · Congress none

ActivistSTATE STREET CORPORATIONSTATE STREET CORPORATION7.0%Aug 7, 2026
ActivistVAVanguard Capital Management5.2%Jul 31, 2026
ActivistBlackRock, Inc.BlackRock, Inc.6.8%Apr 24, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
15.1M(+23.5%)$222.4M0.0%+148.06%
37
Increased
13M(+54.8%)$191.8M0.0%+68.46%
43
Increased
8.2M(+9.3%)$121.4M0.0%+124.56%
33
Increased
4.9M(+24.8%)$72.1M0.0%+154.26%
36
Increased
2.2M(+47.7%)$31.9M0.0%+64.17%
40
Increased
2.1M(+416.4%)$30.3M0.0%+11.71%
46
Increased
2.3M(+37.6%)$28.6M0.0%+82.62%
38
Increased
1.6M(+27.0%)$23.9M0.0%+147.50%
35
Increased
1.3M(+11.0%)$19.7M0.0%+119.80%
32
Increased
1.3M(+68.1%)$18.5M0.0%+52.58%
42
Decreased
1.2M(-7.5%)$18.2M0.0%+352.12%
0
Increased
1.1M(+2180.1%)$15.8M0.0%-3.76%
45
Increased
787,949(+22.8%)$11.6M0.0%+103.99%
34
Increased
597,309(+73.2%)$8.8M0.0%+47.55%
41
Increased
585,035(+5.2%)$8.6M0.0%+217.21%
29
Increased
565,008(+17.6%)$8.3M0.0%+200.28%
32
Increased
530,025(+10.8%)$7.8M0.0%+190.12%
30
New
508,429$7.5M0.0%-6.98%
38
Decreased
418,729(-37.6%)$6.2M0.0%+595.37%
0
Decreased
375,342(-46.2%)$5.5M0.0%+171.37%
0

Showing 1-20 of 119

1 / 6
SLSSLSSELLAS LIFE SCIENCES GROUP I

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used